1Life Healthcare
ONEM
ONEM was delisted on the 21st of February, 2023.
0 hedge funds and large institutions have $0 invested in 1Life Healthcare in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 226 closing their positions.
100% less funds holding
Funds holding: 229 → 0 (-229)
100% less funds holding in top 10
Funds holding in top 10: 18 → 0 (-18)
100% less capital invested
Capital invested by funds: $3.27B → $0 (-$3.27B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 226
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$285M |
| 2 |
CG
Carlyle Group
Washington,
District of Columbia
|
-$227M |
| 3 |
BlackRock
New York
|
-$223M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$141M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$137M |
ONEM Hedge Fund Activity: Q1 2023 in Review
0 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in 1Life Healthcare (ONEM) for Q1 2023, worth a combined $0 — down 100% from $3.27B a quarter earlier.
Sellers outnumbered buyers: 226 funds closed out of ONEM and 0 opened new positions — a net loss of 226 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $285M sold.
- 0 institutional investors held 1Life Healthcare (ONEM) as of Q1 2023, down from 229 in Q4 2022.
- Funds reported $0 of 1Life Healthcare stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new 1Life Healthcare positions in Q1 2023 and 226 closed out, a net change of -226 holders.
- The largest 1Life Healthcare seller in Q1 2023 was Vanguard Group, an estimated $285M sold.
Based on aggregated 13F filings for Q1 2023.